Association between&nbsp;Inhaled&nbsp;&beta;<sub>2</sub>-agonists&nbsp;Initiation and Risk of Major Adverse Cardiovascular Events: A Population-based Nested Case-Control Study

Joseph Emil Amegadzie; John-Michael Gamble; Jamie Farrell; Zhiwei Gao

doi:10.2147/COPD.S358927

open access to scientific and medical research

Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 17

Original Research

Association between Inhaled β₂-agonists Initiation and Risk of Major Adverse Cardiovascular Events: A Population-based Nested Case-Control Study

Total article views		HTML views	PDF downloads	Totals
6,332	Dovepress*	6,209+	285	6,494
	PubMed Central*	123	52	175
	Totals	6,332	337	6,669
*Since 20 May 2022

Total mentioned	Facebook	Delicious	Reddit	Twitter	Others
15	0	0	0	7	8

View citations on PubMed Central and Google Scholar

In order to provide our website visitors and registered users with a service tailored to their individual preferences we use cookies to analyse visitor traffic and personalise content. You can learn about our use of cookies by reading our Privacy Policy. We also retain data in relation to our visitors and registered users for internal purposes and for sharing information with our business partners. You can learn about what data of yours we retain, how it is processed, who it is shared with and your right to have your data deleted by reading our Privacy Policy.

If you agree to our use of cookies and the contents of our Privacy Policy please click 'accept'.

Association between Inhaled β2-agonists Initiation and Risk of Major Adverse Cardiovascular Events: A Population-based Nested Case-Control Study

Association between Inhaled β₂-agonists Initiation and Risk of Major Adverse Cardiovascular Events: A Population-based Nested Case-Control Study